Assessing Risk of Heart Failure: A Closer Look at the Clinical Utility of Galectin-3


Speaker Name/Credentials:

Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP, FNKF
Baylor University Medical Center, Dallas, Texas

Estimated time of Talk

30 minutes


This webcast will overview the heart failure epidemic and biomarker technology currently available to improve patient management and outcomes.

Learning Objectives

  • Review the classical assessment for the identification of heart failure
  • Understand the pathophysiology that drives the initiation and development of heart failure
  • Distinguish Galectin-3 and NT-proBNP as complementary biomarkers of heart failure
  • Review the role of Galetin-3 in the identification and management of heart failure

Target Audience

Primary Care Physicians, Internal Medicine and, Specialists

Conflicts of Interest

Dr. McCullough is a consultant for BG Medicine, Inc.

Share this: